Skip to main content

Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone.

Publication ,  Journal Article
Alexander, KP
Published in: JAMA Cardiol
June 1, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

June 1, 2022

Volume

7

Issue

6

Start / End Page

581 / 582

Location

United States

Related Subject Headings

  • Humans
  • Anticoagulants
  • Aged
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alexander, K. P. (2022). Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone. JAMA Cardiol, 7(6), 581–582. https://doi.org/10.1001/jamacardio.2022.0477
Alexander, Karen P. “Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone.JAMA Cardiol 7, no. 6 (June 1, 2022): 581–82. https://doi.org/10.1001/jamacardio.2022.0477.
Alexander KP. Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone. JAMA Cardiol. 2022 Jun 1;7(6):581–2.
Alexander, Karen P. “Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone.JAMA Cardiol, vol. 7, no. 6, June 2022, pp. 581–82. Pubmed, doi:10.1001/jamacardio.2022.0477.
Alexander KP. Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone. JAMA Cardiol. 2022 Jun 1;7(6):581–582.

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

June 1, 2022

Volume

7

Issue

6

Start / End Page

581 / 582

Location

United States

Related Subject Headings

  • Humans
  • Anticoagulants
  • Aged
  • 3201 Cardiovascular medicine and haematology